The release of puberty blockers on the NHS could draw closer after the health secretary West Streeting revealed his desire for a trial to be “up and running as soon as possible”.
Plans for one were announced in 2024 following the publication of the Cass Review which concluded the quality of studies claiming to show beneficial effects of such medication for children and young people with gender dysphoria was “poor”.
